These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 1924666)
1. Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients. Van Putten T; Aravagiri M; Marder SR; Wirshing WC; Mintz J; Chabert N Psychopharmacol Bull; 1991; 27(2):91-6. PubMed ID: 1924666 [TBL] [Abstract][Full Text] [Related]
2. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine. Marder SR; Van Putten T; Aravagiri M; Hubbard JW; Hawes EM; McKay G; Midha KK Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520 [TBL] [Abstract][Full Text] [Related]
4. Clinical perspectives of some neuroleptics through development and application of their assays. Midha KK; Marder SR; Jaworski TJ; McKay G; Hubbard JW; Hawes EM; Van Putten T; Wirshing WC; Aravagiri M Ther Drug Monit; 1993 Jun; 15(3):179-89. PubMed ID: 8101398 [TBL] [Abstract][Full Text] [Related]
5. Fluphenazine plasma levels and clinical response. Marder SR; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J; Midha KK Psychopharmacol Bull; 1990; 26(2):256-9. PubMed ID: 2236467 [TBL] [Abstract][Full Text] [Related]
7. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. Kong DS; Yeo SH Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894 [TBL] [Abstract][Full Text] [Related]
8. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study. Donlon PT; Swaback DO; Osborne ML Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967 [TBL] [Abstract][Full Text] [Related]
9. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report. Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368 [TBL] [Abstract][Full Text] [Related]
10. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels. Jayaram G; Coyle J; Tune L J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia. Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716 [TBL] [Abstract][Full Text] [Related]
12. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia. Altamura AC; Mauri MC; Girardi T; Panetta B Int J Clin Pharmacol Res; 1990; 10(4):223-8. PubMed ID: 2079381 [TBL] [Abstract][Full Text] [Related]
13. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate. Brown WA; Silver MA J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of neuroleptic in patients receiving depot fluphenazine. Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine. Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250 [TBL] [Abstract][Full Text] [Related]
17. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study. Litman RE; Hong WW; Weissman EM; Su TP; Potter WZ; Pickar D J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200 [TBL] [Abstract][Full Text] [Related]